Product Information
ADDERALL XR 25 MG CAPSULE is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $6.8059 per EA under NDC 54092038901. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 11, 2001. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
ADDERALL XR 25 MG CAPSULE
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine AspartateStrength
6.25; 6.25; 6.25; 6.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
54092038901
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA021303FDA Approved
10/11/2001
TE Code
AB1
On Market Since
5/22/2002
Pharmacological Classes
Price Statistics
The NADAC for ADDERALL XR 25 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.8059 per EA |
|---|---|
| All-time high | $6.9421 (Jun 10, 2015) |
| All-time low | $6.8059 (Sep 23, 2026) |
| 52-week high | $6.8227 |
| 52-week low | $6.8059 |
| Median price | $6.8361 |
| Average price | $6.8543 |
| Largest weekly change | -1.0% (Jun 17, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Takeda Pharmaceuticals America, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ADDERALL XR 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ADDERALL XR 25 MG CAPSULE, manufactured by Takeda Pharmaceuticals America, Inc., is $6.8059 per EA (NDC 54092038901), effective Sep 30, 2026.
How has the price of ADDERALL XR 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ADDERALL XR 25 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ADDERALL XR 25 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ADDERALL XR 25 MG CAPSULE has ranged from a low of $6.8059 (Sep 23, 2026) to a high of $6.9421 (Jun 10, 2015), with a median of $6.8361 per EA.
Are there cheaper alternatives to ADDERALL XR 25 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 25 MG CAP, is $0.4895 per EA — about 93% below ADDERALL XR 25 MG CAPSULE.
Who manufactures ADDERALL XR 25 MG CAPSULE?
ADDERALL XR 25 MG CAPSULE (NDC 54092038901) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.